Is a complete SER research report available?

No complete published report is available for Serina Therapeutics, Inc. (SER) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Serina Therapeutics, Inc. (SER)

NYSEAMERICAN: SER · USD

$1.61

-0.06 (-3.6%)· Recorded snapshot

Market cap	40.9M
Net income (ttm)	-23.9M
EPS (ttm)	-$1.93
Shares out	25.4M
Volume	27,379
Beta	0.16

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -23.9M
EPS (ttm): -$1.93
Market cap: 40.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001708599
Company name	Serina Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	81751A108
Earnings date	2026-11-12
Earnings time	bmo
Employees	16
Employees change	3
Employees growth	23.08%
Enterprise value	$21.6M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
IPO date	2018-11-29
Is primary listing	Yes
Is SPAC	No
ISIN number	US81751A1088
Last 10-K release date	2026-03-25
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$40.9M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$1.61
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SER
U.S. state	Alabama
Website	https://serinatherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001708599

Company name

Serina Therapeutics, Inc.

Country

United States

Country code

CUSIP number

81751A108

Earnings date

2026-11-12

Earnings time

bmo

Employees

Employees change

Employees growth

23.08%

Enterprise value

$21.6M

Exchange

NYSEAMERICAN

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

IPO date

2018-11-29

Is primary listing

Yes

Is SPAC

ISIN number

US81751A1088

Last 10-K release date

2026-03-25

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$40.9M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$1.61

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

SER

U.S. state

Alabama

Website

https://serinatherapeutics.com

Metric	Value
Earnings yield	-120.18%
FCF / EV yield	-91.59%
FCF yield	-49.98%
P/B ratio	2.26x
Price / tangible book value	2.26x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-120.18%

FCF / EV yield

-91.59%

FCF yield

-49.98%

P/B ratio

2.26x

Price / tangible book value

2.26x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.5M
ROA	-92.3%
ROCE	-116.37%
ROE	-207.94%
ROIC	-130.98%

Metric

Value

Profit per employee

$-1.5M

ROA

-92.3%

ROCE

-116.37%

ROE

-207.94%

ROIC

-130.98%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth	132.14%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth

132.14%

Revenue growth years

Metric	Value
Capital expenditures	$-66,000
Depreciation and amortization	$76,000
EBIT	$-25.7M
EBITDA	$-25.6M
EPS	$-1.93
FCF per share	$-0.83
Financing cash flow	$38.2M
Free cash flow	$-21.2M
Free cash flow minus SBC	$-25.3M
Gross profit	$-14.1M
Income taxes	$18,000
Investing cash flow	$-66,000
Net borrowing	$4.9M
Net cash flow	$17M
Net income	$-23.9M
Operating cash flow minus SBC	$-25.2M
Operating income	$-25.7M
Stock-based compensation	$4.1M

Metric

Value

Capital expenditures

$-66,000

Depreciation and amortization

$76,000

EBIT

$-25.7M

EBITDA

$-25.6M

EPS

$-1.93

FCF per share

$-0.83

Financing cash flow

$38.2M

Free cash flow

$-21.2M

Free cash flow minus SBC

$-25.3M

Gross profit

$-14.1M

Income taxes

$18,000

Investing cash flow

$-66,000

Net borrowing

$4.9M

Net cash flow

$17M

Net income

$-23.9M

Operating cash flow minus SBC

$-25.2M

Operating income

$-25.7M

Stock-based compensation

$4.1M

Metric	Value
Altman Z-Score	-3.31
Book value per share	$0.74
Debt / equity	0.2
Interest coverage	-43.06
Long-term assets	$784,000
Long-term liabilities	$3.3M
Net cash (debt)	$19.3M
Net cash / market cap	45.43%
Net cash growth	239.32%
Net debt / equity	-1.03
Piotroski F-Score	2
Property, plant and equipment	$759,000
Shareholders' equity	$18.7M
Tangible book value	$18.7M
Tangible book value per share	$0.74
Total assets	$25.8M
Total cash	$23M
Total debt	$3.8M
Total liabilities	$7.1M
WACC	5.71%

Metric

Value

Altman Z-Score

-3.31

Book value per share

$0.74

Debt / equity

0.2

Interest coverage

-43.06

Long-term assets

$784,000

Long-term liabilities

$3.3M

Net cash (debt)

$19.3M

Net cash / market cap

45.43%

Net cash growth

239.32%

Net debt / equity

-1.03

Piotroski F-Score

Property, plant and equipment

$759,000

Shareholders' equity

$18.7M

Tangible book value

$18.7M

Tangible book value per share

$0.74

Total assets

$25.8M

Total cash

$23M

Total debt

$3.8M

Total liabilities

$7.1M

WACC

5.71%

Metric	Value
Current assets	$25M
Current liabilities	$3.8M
Current ratio	6.65
Net working capital	$-1.2M
Quick ratio	6.12
Working capital	$21.3M

Metric

Value

Current assets

$25M

Current liabilities

$3.8M

Current ratio

6.65

Net working capital

$-1.2M

Quick ratio

6.12

Working capital

$21.3M

Metric	Value
Buyback yield / dilution	-30.5%
Dividend yield	0%
Shareholder yield	-30.5%

Metric

Value

Buyback yield / dilution

-30.5%

Dividend yield

Shareholder yield

-30.5%

Metric	Value
150-day SMA	$2.07
1D price change	-3.59%
1M price change	-22.04%
1M total return	-22.04%
1W price change	-1.85%
1W total return	-1.85%
1Y price change	-67.86%
1Y return CAGR	-67.89%
1Y total return	-67.86%
20-day SMA	$1.82
200-day SMA	$2.10
3M price change	-22.41%
3M total return	-22.41%
50-day SMA	$2.18
50-day SMA vs 200-day SMA	50over200
52-week high	$5.09
52-week high date	2025-10-28
52-week low	$1.22
52-week low date	2026-03-18
6M price change	-9.48%
6M total return	-9.48%
All-time high	$19.93
All-time high date	2024-03-27
All-time low	$1.22
All-time low date	2026-03-18
Average true range (ATR)	$0.18
Average volume	41.2K
Beta (1Y)	1.37
Beta (2Y)	0.26
Beta (5Y)	0.16
Change from 52-week high	-68.37%
Change from 52-week low	31.97%
Change from all-time high	-91.82%
Change from all-time low	33.55%
Change from open	0%
Day's gap	-3.59%
Dollar volume	$44,080
High price	$1.61
Low price	$1.61
Monthly RSI	24.09
Open price	$1.61
Premarket change	-0.6%
Premarket close	$1.67
Premarket price	$1.66
Previous close	$1.67
Price vs 150-day SMA	-21.14%
Price vs 20-day SMA	-10.67%
Price vs 200-day SMA	-22.27%
Price vs 50-day SMA	-25.26%
Relative volume	0.66
RSI	34.33
Sharpe ratio	-0.28
Sortino ratio	-0.49
Volume	27.4K
Weekly RSI	38.87
YTD price change	-14.83%
YTD total return	-14.83%

Metric

Value

150-day SMA

$2.07

1D price change

-3.59%

1M price change

-22.04%

1M total return

-22.04%

1W price change

-1.85%

1W total return

-1.85%

1Y price change

-67.86%

1Y return CAGR

-67.89%

1Y total return

-67.86%

20-day SMA

$1.82

200-day SMA

$2.10

3M price change

-22.41%

3M total return

-22.41%

50-day SMA

$2.18

50-day SMA vs 200-day SMA

50over200

52-week high

$5.09

52-week high date

2025-10-28

52-week low

$1.22

52-week low date

2026-03-18

6M price change

-9.48%

6M total return

-9.48%

All-time high

$19.93

All-time high date

2024-03-27

All-time low

$1.22

All-time low date

2026-03-18

Average true range (ATR)

$0.18

Average volume

41.2K

Beta (1Y)

1.37

Beta (2Y)

0.26

Beta (5Y)

0.16

Change from 52-week high

-68.37%

Change from 52-week low

31.97%

Change from all-time high

-91.82%

Change from all-time low

33.55%

Change from open

Day's gap

-3.59%

Dollar volume

$44,080

High price

$1.61

Low price

$1.61

Monthly RSI

24.09

Open price

$1.61

Premarket change

-0.6%

Premarket close

$1.67

Premarket price

$1.66

Previous close

$1.67

Price vs 150-day SMA

-21.14%

Price vs 20-day SMA

-10.67%

Price vs 200-day SMA

-22.27%

Price vs 50-day SMA

-25.26%

Relative volume

0.66

RSI

34.33

Sharpe ratio

-0.28

Sortino ratio

-0.49

Volume

27.4K

Weekly RSI

38.87

YTD price change

-14.83%

YTD total return

-14.83%

Metric	Value
Float	11.1M
Float percentage	43.89%
Shares change (QoQ)	36.01%
Shares change (YoY)	30.5%
Shares held by insiders	39.67%
Shares held by institutions	5.55%
Shares outstanding	25.4M
Short % of float	0.51%
Short % of shares	0.22%
Short ratio	0.6 days

Metric

Value

Float

11.1M

Float percentage

43.89%

Shares change (QoQ)

36.01%

Shares change (YoY)

30.5%

Shares held by insiders

39.67%

Shares held by institutions

5.55%

Shares outstanding

25.4M

Short % of float

0.51%

Short % of shares

0.22%

Short ratio

0.6 days

Serina Therapeutics, Inc. (SER)

Price

Financial snapshot

Fair-value bridge

Latest news · SER

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SER indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SER

Frequently asked questions